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Background:  Viral  Infectious  clone  systems  serve  as  robust  platforms  to study  viral  gene  or replicative
function  by  reverse  genetics,  formulate  vaccines  and adapt  a wild type-virus  to  an  animal  host.  Since
the  development  of  the ﬁrst viral  infectious  clone  system  for the  poliovirus,  novel  strategies  of  viral
genome  construction  have  allowed  for  the  assembly  of viral  genomes  across  the  identiﬁed  viral  families.
However,  the molecular  proﬁles  of some  viruses  make  their  genome  more  difﬁcult  to  construct  than
others.  Two  factors that affect  the difﬁculty  of infectious  clone  construction  are  genome  length  and
genome  complexity.
Results: This  work  examines  the  available  strategies  for overcoming  the  obstacles  of assembling  the  long
and  complex  RNA genomes  of  coronaviruses  and  reports  one-step  construction  of an  infectious  clone
system  for  the  Middle  East  Respiratory  Syndrome  coronavirus  (MERS-CoV)  by  homologous  recombinationeverse genetics
omologous recombination
in  S.  cerevisiae.
Conclusions:  Future  use  of this  methodology  will shorten  the  time  between  emergence  of  a novel  viral
pathogen  and construction  of  an infectious  clone  system.  Completion  of  a viral  infectious  clone  system
facilitates  further  study  of  a  virus’s  biology,  improvement  of diagnostic  tests,  vaccine  production  and  the
poun
ht  ©  2screening  of antiviral  com
Crown  Copyrig
. Background
In June of 2012, the Middle East Respiratory Syndrome (MERS)
oronavirus (CoV) was isolated from a patient suffering from symp-
oms of respiratory disease in Jeddah, Kingdom of Saudi Arabia
Zaki et al., 2012). MERS-CoV genetically clusters with the bat coro-
aviruses Neoromicia/PML, HKU4-1 and HKU5-1 which occupy
ineage C of the betacoronaviridae,  no other identiﬁed human coro-
avirus exists within this genus (Raj et al., 2014). Epidemiological
tudies of MERS-CoV implicate camels as a possible zoonotic host
Memish et al., 2014; Reusken et al., 2013). Since its emergence,
ERS-CoV has spread between 26 countries causing 1375 labora-
∗ Corresponding author at: 1015 Arlington Street, Winnipeg, Manitoba, R3E 3P6,
anada.
E-mail address: steven.theriault@phac-aspc.gc.ca (S.S. Theriault).
ttp://dx.doi.org/10.1016/j.jviromet.2016.07.022
166-0934/Crown Copyright © 2016 Published by Elsevier B.V. This is an open access ar
d/4.0/).ds.
016  Published  by Elsevier  B.V.  This  is an  open  access  article  under  the  CC
BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
tory conﬁrmed cases and 587 deaths (ECDC, 2015; ProMED-mail,
2016). No other coronavirus has so greatly impacted public health,
or global economics since severe acute respiratory syndrome coro-
navirus (SARS-CoV) in 2002 (Hilgenfeld and Peiris, 2013). The
unexpected introduction of SARS-CoV and MERS-CoV into the
human population combined with a lack of current antiviral ther-
apies or vaccines to protect the public from coronavirus related
disease, makes study of these and similar viruses important to
public health. In order to improve the timeline between discovery
of a novel coronavirus and completion of an infectious clone sys-
tem, we undertook the rapid construction of the MERS-CoV cDNA
genome EMC/2012 (JX869059.2) by homologous recombination in
S. cerevisiae.Virus infectious clone systems allow for the expression of a
homogenous virus population within mammalian cell culture from
a sequence of DNA or RNA (Ebihara et al., 2005). The construction
of such systems for RNA viruses involves several steps: 1) pos-
ticle under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
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ession of a virus isolate, 2) sequencing of the viral genome, 3)
everse transcription of the viral RNA genome to complementary
NA (cDNA) and 4) assembly of the PCR cDNA amplicons into the
ull-length genome. The timing and technical expertise required
o perform these steps depends on the type of viral genome being
onstructed. Infectious clone systems for viruses with small un-
ragmented positive sense RNA genomes are less demanding to
onstruct than those with large negative sense, positive sense or
ragmented genomes (Ebihara et al., 2005; Yount et al., 2000;
tobart and Moore, 2014).
Construction of infectious clone systems for viruses of the
oronaviridae has lagged in comparison to those of other viral fam-
lies because qualities of the coronavirus genome restrict the use
f traditional molecular cloning techniques (Stobart and Moore,
014). The prototypical coronavirus possesses a positive sense RNA
enome from 27 to 32 kb in length. Multiple regions of sequence
edundancy exist (Gorbalenya et al., 2006), whichdecrease the
vailability of unique restriction sites. The MERS-CoV genome
JX869059.2) has only 12 unique restriction sites (Fig. 1a); their
ositions and the sizes of the corresponding DNA fragments pre-
lude a simple cloning strategy. Highly cytotoxic regions have
lso been described within coronavirus genomes, which cause
. coli cloning strains to poorly tolerate plasmids carrying corona-
irus genome cassettes (González et al., 2002; Yount et al., 2002).
erforming polymerase chain reaction (PCR), especially reverse
ranscription PCR (RT-PCR) on coronavirus genomes proves trou-
lesome, as the error rate of DNA polymerases increases in relation
o copy number and amplicon size (Eckert and Kunkel, 1991).
n combination, these factors make the assembly of coronavirus
enome’s by traditional molecular cloning tedious and time con-
uming (Almazán et al., 2014; Enjuanes, 2005). Virologists have
eveloped several alternative methods to overcome these obsta-
les; however, none of them allow for rapid construction and
xpression of a coronavirus infectious clone system. The attempted
ig 1. (a) Illustration of the MERS-CoV/EMC-2012 genome, the location of unique restri
enome was  assembled from three large fragments by homologous recombination. Prime
nd  blue (MF3). The full sequences of primers are shown in Table 1.0. (c) The complete M
lements necessary for transcription of viral RNA (for interpretation of the references to ccal Methods 236 (2016) 178–183 179
strategies include targeted RNA recombination, transfection of
multiple or single plasmid vectors and vaccinia virus transduction.
Almazan et al. conducted a concise summary of available strate-
gies for coronavirus genome construction in their 2014 review. In
summary, they concluded that several alternatives to conventional
approaches have beneﬁted the science of coronavirus genome
construction over the last thirteen years. We  hypothesize that con-
struction of a coronavirus genome by homologous recombination
within S. cerevisiae,  will prove an additional efﬁcient means to
molecular cloning coronaviruses while preserving the strengths of
the plasmid based method: long term stability and efﬁcient expres-
sion (Fig. 1c) (Almazán et al., 2014).
2. Methods
2.1. Chemical synthesis of MERS-CoV cDNA, plasmid selection
and primer design
Thirty-one, 1-kb gene fragments of the MERS-CoV EMC/2012
genome (NC 019843.2, JX869059.2) were chemically synthesized
and cloned into the EcoR1 sites of pCR® 2.1 (Life Technologies)
by Euroﬁns MWG  Operon. The pYES1L-BAC vector (Life Technolo-
gies) was chosen for conducting homologous recombination in S.
cerevisiae and maintenance of the completed MERS-CoV infectious
clone system in E. coli. Primers were designed for stepwise assembly
of the synthetic MERS-CoV gene fragments and amplifying products
for homologous assembly in S. cerevisiae (Table 1.0 and Supplemen-
tary Table 1.0).
2.2. Assembly of MERS-CoV cDNA by polymerase chain reactionThe 1-kb MERS-CoV gene fragments and regulatory genetic
elements (i.e. cytomegalovirus promoter, beta globulin termina-
tor and hepatitis delta virus ribozyme) were stepwise assembled
ction sites are shown. (b) A full-length cDNA version of the MERS-CoV/EMC-2012
rs sharing end homology are coded by color: black (vector), green (MF1), red (MF2)
ERS-CoV infectious clone system, including the pYES1L-BAC vector and regulator
olor in this ﬁgure legend, the reader is referred to the online version of this article.)
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Table  1
Oligo-nucleotide primers used for assembly of MERS-CoV cDNA by homologous recombination.
Primer Name Use Sequence (5′–3′)
CMVpF MF1-F CGCTGATACCGCCGCTATTAATAGTAATCAATTACGGGGTCAT
M-CoV6, 000R MF1-R ATTCTTATAAATAGGGTCATAAGTGTCAAACTCAGCCAACA
M-CoV6, 001F MF2-F GTTGGCTGAGTTTGACACTTATGACCCTATTTATAAGAATGGT
M-CoV18, 000R MF2-R GGCCAGTTACAATCTGAGACTGGAGCTTGTAATTAGTAAAAGA
M-CoV18, 001F MF3-F TCTTTTACTAATTACAAGCTCCAGTCTCAGATTGTAACTGGCC
BGTR MF3-R TTAACTGCGGCGAGGCAGCATATGGCATATGTTGCCAAACTCTAAACCAAATAC
pYES1L F Vector CATATGCCATATGCTGCCTCGCCGCAGTTAATTAAAGTCA
pYES1L R Vector TGATTACTATTAATAGCGGCGGTATCAGCG
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Mrimers containing ∼ 30 bps of homology between MERS-CoV cDNA fragments (MF1,
or  assembly by homologous recombination.
y splice-by-overlap extension polymerase chain reaction. Three
arge PCR amplicons were produced by this method ranging
rom: (MF1) CMVpF Start (TATTA)- EMC/2012 (6023 bp), (MF2)
MC/2012 (5981 bp)-EMC/2012 (18,020 bp) and (MF3) EMC/2012
17,978 bp)- Beta-Globulin Terminator end (TGCTC). The three
emplates MF1, MF2  and MF3  were PCR ampliﬁed using primers
ith ∼30 bps of homology to the neighbouring fragment or blunt
nds of the pYES1L vector (Fig. 1b) (Table 1) with PrimeSTAR®
XL polymerase. The resulting amplicons were puriﬁed by
el electrophoresis and extracted using the NucleoSpin® kit
Macherey-Nagel). The elution buffer NE was pre-warmed to 70 ◦C
o increase the yield of puriﬁed DNA from the silica membrane spin
olumns. MF1,MF2 and MF3  were not subcloned into maintenance
ectors, instead they were transfected directly into the yeast cells
or homologous recombination.
ig 2. (a,b) Transformed S. cerevisiae colonies were screened for the MERS-CoV/pYES1L pl
ACAATCTATA and R- AGTTGCAAACCTTATACGGTATGGTTGCAACTTTCTTAAAGGAC, Pri
TAACTGCGGCGAGGCAGCATATGGCATATGTTGCCAAACTCTAAACCAAATAC). Each well (1
ng  an amplicon for both Primer set 1 and Primer set 2. (c) Cellular supernatant was  
SARS-CoV virus and used in a RT-PCR assay to detect a region of the MERS-CoV polym
nd  R- TGTGAGAGGGTAAGCATCTATAGCCAAAGACACAAACCGCT). The MERS-CoV polym
rSARS-CoV supernatant). Lane 3 serves as a positive control, it shows PCR ampliﬁcati
olymerase gene fragment ampliﬁed from rMERS-CoV infected cell supernatant was  sequ
aviruses: CoV-HKU4-1 (NC 009019.1), CoV-HKU5-1 (NC 009020.1), SARS-CoV/Tor 2 (N
ERS-CoV/EMC/2012 (NC 019843.3).nd MF3) and the pYES1L-BAC vector were used to amplify the regions in preparation
2.3. Homologous recombination of MERS-CoV cDNA
Homologous recombination of the three MERS-CoV gene frag-
ments (MF1, MF2  and MF3) and the pYES1L-BAC vector was
performed using the GeneArt® High-Order Genetic Assembly Sys-
tem (Life Technologies). Chemically induced MaV203 cells (Life
Technologies) were transformed with 100 ng of pYES1 L Vector,
173 ng of MF1, 205 ng of MF2  and 100 ng of MF3. Transformed
cells were grown on complete supplement mixture deﬁcient in
tryptophan (CSM-Trp) agar plates for three days at 30 ◦C. The result-
ing colonies were replica plated and screened for presence of the
®MERS-CoV genome by PCR with the GoTaq polymerase (Promega).
S. cerevisiae cells were disrupted by suspension in 30 L of 0.2%
w/v sodium dodecyl sulfate (SDS) (Sigma-Aldrich) and heat treat-
ment at 95 ◦C for 5 min. The samples were diluted with 20 L of
asmid vector by PCR (Primer Set 1: F- GTGCTGATGACGAAGGCTTCATCACATTAAAG-
mer Set 2: F- AAGCTTGCACCATGTTGAAACTTTTGGTGGAAGTGCGCTTGT and R-
–23) represents a single colony; positive colonies were deﬁned as those produc-
withdrawn from cells infected with either rescued rMERS-CoV virus or rescued
erase gene (Primer set: F-CAAGATGAACTTTTTGCCATGACAAAGCGTAACGTCATTCC
erase gene was  detected in Lane 1 (rMERS-CoV supernatant) and not Lane 2
on of the MERS-CoV polymerase gene from the infectious clone system. (d) The
enced and used in a phylogenetic comparison (ClustalW Algorithim) with six coro-
C 004718.3), CoV-Neoromicia/PML (KC 869678.4), CoV-229E (NC 002645.1) and
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ells.  These Vero cells were incubated for 3 days and observed for CPE. CPE was  not
ndicating rescue of infectious virus (rMERS-CoV).
uclease-free water and chilled on wet ice. Half of a microliter
f lysed S. cerevisiae colony supernatant was used as a template
n PCR reactions. Positively screened colonies were grown in 5 mL
olumes of CSM-Trp liquid media and the pYES1L-BAC/MERS-CoV
lasmids were isolated using the Easy Yeast plasmid Isolation Kit
Takara, Clontech). A 5 L volume of isolated plasmid was elec-
roporated into Max  Efﬁciency DH10B cells (Life Technologies).
H10B colonies were screened by PCR with GoTaq® polymerase
nd positive pYES1L-BAC/MERS-CoV plasmids were isolated using
he HiSpeed Plasmid Maxi Kit (Qiagen). To view the primers used
or the screening reactions refer to the caption of Fig. 2 (Fig. 2a and
).
.4. Sequencing of the MERS-CoV genome
The assembled MERS-CoV genome was sequenced by Sanger
equencing at the DNA Core Facility, Canadian Science Centre for
uman and Animal Health, Winnipeg, Manitoba. The sequences
ere aligned and interpreted using the SeqMan Pro software of the
NASTAR Lasergene 11 Core Suite.
.5. Rescue of infectious MERS-CoV virus from the infectious
lone system
Functionality of the MERS-CoV infectious clone system was
xamined by rescue in mammalian cell culture. Baby Ham-
ter Kidney cells (BHK-21) (ATCC: CCL-10TM) were grown in a
75 ﬂask (NUNC) in Eagle’s Minimal Essential Medium (EMEM)
upplemented with 5% v/v fetal bovine serum and 1% v/v peni-
illin/streptomycin (HyClone) to full conﬂuence at 37 ◦C 5%
O2. Transfection complexes of pYES1L-BAC/MERS-CoV plasmid
300 ng) were prepared in Opti-MEMTM(Life Technologies) using
ugene6® (Promega) transfection reagent and added to a 6-well
late of 70% conﬂuent BHK-21 following 15 min  of incubation at
oom temperature. The transfected BHK-21 cells were incubated
vernight at 37 ◦C, 5% CO2. They were then treated with 0.25% v/v
rypsin-EDTA (GibcoTM) and a suspension of BHK-21 cells was over-pYES1L plasmid was  blind passaged three times to infect a fresh culture of Vero
the cells infected with the blind passage supernatant and not the negative control,
laid onto a monolayer of Vero Cells (ATCC: CCL-81) grown to ∼80%
conﬂuence in a T75 ﬂask with Dulbecco’s modiﬁed eagle medium
(DMEM) supplemented with 5% v/v fetal bovine serum and 1% v/v
penicillin/streptomycin. The Vero cells were incubated at 37 ◦C, 5%
C02 for 3 days and then examined for cytopathic effect. The same
protocol was used to rescue SARS-CoV virus from an infectious
clone system as a control.
2.6. Conﬁrmation of MERS-CoV virus rescue
Three techniques were used to conﬁrm the rescue of infectious
MERS-CoV (rMERS-CoV) virus from the infectious clone system.
Production of infectious virions from the Vero/BHK-21 cell overlay
was conﬁrmed by triplicate blind passage of the cellular super-
natant into fresh cultures of Vero Cells grown in a T150 in DMEM
with 2% v/v fetal bovine serum and 1% v/v penicillin/streptomycin.
Supernatant from the third blind passage was collected at 72 h post
infection and rMERS-CoV RNA was  extracted using the Viral RNA
isolation kit (Qiagen). The viral RNA was  treated with DNase I (New
England Biolabs) to eliminate any plasmid contamination before
being used as a template for reverse transcriptase PCR carried out
with Superscript IITM(Thermo Fisher) (First Strand Primer: TGT-
GAGAGGGTAAGCATCTATAGCCAAAGACACAAACCGCT and Forward
Primer: CAAGATGAACTTTTTGCCATGACAAAGCGTAACGTCATTCC).
The ampliﬁed cDNA was  then treated with RNase H (New Eng-
land Biolabs) before being removed from a containment level three
laboratory (CL-3). The RT-PCR amplicon was  sequenced by the
Sanger method and used for phylogenetic comparison with other
coronavirus sequences taken from NCBI Genbank. Stocks of the
rMERS-CoV virus were frozen at −80 ◦C degrees. These stocks were
later used to compare growth kinetics of the rescued virus with the
wild type MERS-CoV EMC/2012 virus.2.7. MERS-CoV growth kinetics
Growth kinetics of the virus rescued from the infectious clone
system rMERS-CoV and the clinical isolate MERS-CoV/EMC-2012
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t  an MOI of 0.001 and virus titre was measured every 24 h for 72 h. The viruses sh
he  clinical isolate. Error bars represent the standard error of the mean +/− from the
ere compared by infection of Vero cells in a 12 well tissue culture
late at an MOI  of 0.001. Vero Cell supernatants were collected at
4, 48 or 72 h post infection and virus titre was quantiﬁed by TCID50
ssay.
.8. Phylogenetic analysis
The RT-PCR amplicon of rMERS-CoV was sequenced as described
n Section 2.4. The sequence was then aligned with the genomes
f six other coronaviruses, downloaded from Genbank, using the
egAlign Pro software available from the DNASTAR Lasergene
1 Core Suite. The ClustalW algorithm was chosen to compute
he alignment of the RT-PCR amplicon from rMERS-CoV with the
orresponding sequence of: MERS-CoV/EMC-2012, BtCoV-HKU4-1,
tCoV-HKU5-1, SARS-CoV/TOR2 and CoV-229E.
.9. Statistical methods
The error bars in Fig. 4 were generated in GraphPad Prism by
alculating the standard error of the mean across the biological
eplicates. The resulting values were then added and subtracted
rom the mean value of each time point.
. Results
.1. Successful assembly of the MERS-CoV genome by
omologous recombination in S. cerevisiae
Transformation of three MERS-CoV DNA fragments (MF1, MF2,
F3) (Fig. 1b) and the pYES1L vector into S. cerevisiae MaV203 cells
ielded an assembled MERS-CoV infectious clone system. The pro-
edure seemed quite robust as the 578 ng of input DNA produced
ver 200 yeast colonies (TNTC) on the selective media, the tech-
ique was performed four times and each attempt produced an
ntact full-length genome. This approach has also successfully con-
tructed a variety of smaller expression plasmid constructs (Ma
t al., 1987). Screening S. cerevisiae colonies by PCR with two primer
ets detected the MERS-CoV genome in 22/23 samples indicating
hat the transformation, homologous recombination and screening
rocesses share a combined efﬁciency of approximately 95% (Fig. 2a
nd b). The MERS-CoV/pYES1L vector was sequenced by the Sanger
ethod and the viral cDNA genome was 100% identical with that
f the isolate MERS-CoV/EMC-2012.te MERS-CoV/EMC-2012 over a time course of 72 h. Vero cells were initially infected
eplication kinetics concluding that rMERS-CoV serves as a biological surrogate for
 of three biological replicates.
3.2. Conﬁrmation of MERS-CoV virus rescue from the infectious
clone system
The utility of the MERS-CoV/pYES1L infectious clone system
was examined via several techniques in BHK21 and Vero cells.
Cytopathic effect suggestive of viral infection was observed when
BHK21 cells transfected with the MERS-CoV/pYES1L plasmid were
overlaid onto a monolayer of Vero cells. The presence of infectious
viral particles in the cellular supernatant was  conﬁrmed by three
blind passages in Vero cells (Fig. 3). Viral RNA extracted from the
medium of infected Vero cells was  tested for MERS-CoV RNA by
RT-PCR (Fig. 2c); the identity of the rescued virus was conﬁrmed as
MERS-CoV/EMC-2012 by sequencing and phylogenetic analysis of
the RT-PCR amplicon (Fig. 2d). Finally, comparison of rMERS-CoV
ﬁtness to that of the clinical isolate MERS-CoV/EMC-2012 over a
time course of 72 h, showed similar results. The two viruses shared
replication kinetics, implying that the rescued virus serves as an
accurate phenotypic surrogate for the clinical isolate (Fig. 4).
4. Discussion
Construction of infectious clone systems by homologous recom-
bination in S.cerevisiae has potential to become the standard
method for construction of coronavirus genomes or those of other
similarly large and complex viruses. Use of our method avoided
some of the obstacles to coronavirus genome assembly reported by
other authors. For instance, regions of the coronavirus genome that
show cytotoxicity in E. coli had no observed affect on the growth of
S. cerevisiae.  The issue of restriction site scarcity was also avoided,
because unique sites were not needed to complete construction
of the system. The strategy of homologous recombination seems
particularly attractive when combined with the availability of viral
genome sequences on Genbank and the commercial synthesis of
cDNA fragments. These three resources, allow for the rapid con-
struction of a viral infectious clone system without possession of
a viral isolate or great risk of introducing mutations into a viral
genome during repeated RT-PCR and PCR ampliﬁcation. Combin-
ing homologous recombination in S. cerevisiae with other modern
molecular methods (i.e: Gibson Assembly®) may  further shorten
the construction time of viral infectious clone systems (Gibson et al.,
2010). Interestingly two  other methods of coronavirus genome
assembly (Targeted RNA recombination, and use of a Vaccinia virus
backbone) both involve a variation of the homologous recombina-
tion mechanism (Almazán et al., 2014). Homologous recombination
in S. cerevisiae builds upon these technologies because it allows for
single-step construction of the viral cDNA genome in a BAC vector.
The BAC based design does not have the stability issues of a targeted
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Two other infectious clone systems for MERS-CoV have
een constructed and used to make a replication-competent
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Almazán et al., 2013; Scobey et al., 2013). Many additional uses of
uch systems remain including further reverse genetics studies on
oronavirus non-structural genes, adaption of the viral genome to
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ines (Cook et al., 2012; Stobart and Moore, 2014). Future studies
ill utilize our system to better understand coronavirus replica-
ive function and potentially prepare vaccines or treatments against
ERS-CoV.
. Conclusion
The use of homologous recombination in S.cerevisiae allowed
or rapid- single-step- construction of a MERS-CoV infectious clone
ystem, making it a promising candidate methodology for future
ssembly of large and complex viral genomes or those of recently
merged zoonotic viruses.
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